BackMolecular Data Overview

Molecular Data Receivables

Latest receivables for MKD: $93M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$92.77M

Peer average

Loading

Molecular Data Receivables History

Loading

Molecular Data vs. peers: Receivables Comparison

Loading

Molecular Data Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Molecular Data (MKD) FAQ

Molecular Data (MKD) currently reports a receivables of $93M as of September 2021. Use the charts on this page to explore Molecular Data's receivables history and peer comparisons.

Molecular Data reported $93M in receivables as of September 2021. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $93M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Molecular Data, and consider following MKD for alerts when major investors trade the stock.

Molecular Data is classified in the Industrials sector. On receivables, it currently shows $93M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing MKD with unrelated industries.